Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.

Zhao Z, Ning J, Bao XQ, Shang M, Ma J, Li G, Zhang D. · 2021

Read Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. by Zhao Z, Ning J, Bao XQ, Shang M, Ma J, Li G, Zhang D. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8597301.txt.

Description

Zhao and co-authors test fecal microbiota transfer in mice with a Parkinson-like illness. Gut problems often come with Parkinson disease. Changes in gut microbes may send signals to the brain. The team used rotenone to cause the illness in mice, then gave a transfer of gut microbes.

Rotenone changed the gut mix and harmed gut function and movement. Two microbe groups grew more common in the sick mice. The transfer restored the gut mix and eased gut and movement problems. It also lowered gut inflammation and repair harm to the gut wall. The authors link the benefit to a gut signal path that involves a known immune sensor.

Catalog record

CREATORZhao Z, Ning J, Bao XQ, Shang M, Ma J, Li G, Zhang D.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE104 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8597301

Browse the full library · About the Tower of Babel